Literature DB >> 15615865

Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors.

Michelle A Uberti1, Chris Hague, Heide Oller, Kenneth P Minneman, Randy A Hall.   

Abstract

The alpha1D-adrenergic receptor (alpha1D-AR) is a G protein-coupled receptor (GPCR) that is poorly trafficked to the cell surface and largely nonfunctional when heterologously expressed by itself in a variety of cell types. We screened a library of approximately 30 other group I GPCRs in a quantitative luminometer assay for the ability to promote alpha1D-AR cell surface expression. Strikingly, these screens revealed only two receptors capable of inducing robust increases in the amount of alpha1D-AR at the cell surface: alpha1B-AR and beta2-AR. Confocal imaging confirmed that coexpression with beta2-AR resulted in translocation of alpha1D-AR from intracellular sites to the plasma membrane. Additionally, coimmunoprecipitation studies demonstrated that alpha1D-AR and beta2-AR specifically interact to form heterodimers when coexpressed in HEK-293 cells. Ligand binding studies revealed an increase in total alpha1D-AR binding sites upon coexpression with beta2-AR, but no apparent effect on the pharmacological properties of the receptors. In functional studies, coexpression with beta2-AR significantly enhanced the coupling of alpha1D-AR to norepinephrine-stimulated Ca2+ mobilization. Heterodimerization of beta2-AR with alpha1D-AR also conferred the ability of alpha1D-AR to cointernalize upon beta2-AR agonist stimulation, revealing a novel mechanism by which these different adrenergic receptor subtypes may regulate each other's activity. These findings demonstrate that the selective association of alpha1D-AR with other receptors is crucial for receptor surface expression and function and also shed light on a novel mechanism of cross talk between alpha1- and beta2-ARs that is mediated through heterodimerization and cross-internalization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615865     DOI: 10.1124/jpet.104.079541

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  53 in total

1.  Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.

Authors:  Rajib K Paul; Anuradha Ramamoorthy; Jade Scheers; Robert P Wersto; Lawrence Toll; Lucita Jimenez; Michel Bernier; Irving W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2012-07-09       Impact factor: 4.030

2.  Rescue of misrouted GnRHR mutants reveals its constitutive activity.

Authors:  Jo Ann Janovick; Irina D Pogozheva; Henry I Mosberg; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2012-05-17

Review 3.  GPCRs and Signal Transducers: Interaction Stoichiometry.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2018-05-05       Impact factor: 14.819

4.  Receptor heterodimerization: a new level of cross-talk.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

5.  Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment.

Authors:  Katharine Herrick-Davis; Ellinor Grinde; Barbara A Weaver
Journal:  Eur J Pharmacol       Date:  2007-05-04       Impact factor: 4.432

Review 6.  GPCR monomers and oligomers: it takes all kinds.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Neurosci       Date:  2008-01-15       Impact factor: 13.837

Review 7.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

8.  How and why do GPCRs dimerize?

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2008-04-01       Impact factor: 14.819

Review 9.  Subtypes of functional alpha1-adrenoceptor.

Authors:  James R Docherty
Journal:  Cell Mol Life Sci       Date:  2009-10-28       Impact factor: 9.261

10.  Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones.

Authors:  Hiroyuki Kobayashi; Koji Ogawa; Rong Yao; Olivier Lichtarge; Michel Bouvier
Journal:  Traffic       Date:  2009-06-09       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.